Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth Pienta currently holds 2,000 shares of Cue Biopharma, Inc. (CUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth Pienta has been a net seller of CUE stock. They have purchased $158.7K and sold $550.7K worth of shares.
Kenneth Pienta's most recent insider trade was on Mar 16, 2021, when they sold 439 shares at $15.09 per share.
Kenneth Pienta serves as Executive at Cue Biopharma, Inc. (CUE). They have executed 15 insider transactions totaling $709.4K over their tenure at the company.
Kenneth Pienta holds the position of Executive at Cue Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Kenneth Pienta has shown a selling trading pattern, with $158.7K in total purchases and $550.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kenneth Pienta was on Feb 16, 2021, when they sold $242.4K worth of CUE shares. This transaction involved 16,000 shares at $15.15 per share.
Kenneth Pienta currently owns 2,000 shares of Cue Biopharma, Inc. (CUE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth Pienta's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth Pienta has 15 Form 4 filings on record as an insider at Cue Biopharma, Inc..
Set alerts for Kenneth Pienta and 40,000+ other insiders.